Second line of treatment for HER2-positive gastric cancer: an evolving issue

von Roviello, Giandomenico, Catalano, Martina, D’Angelo, Alberto, Palmieri, Valeria Emma
Veröffentlicht in Rep Pract Oncol Radiother (2021)

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights

von Roviello, Giandomenico, D'Angelo, Alberto, Roudi, Raheleh, Petrioli, Roberto, Mini, Enrico
Veröffentlicht in J Oncol (2019)

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

von Roviello, Giandomenico, Corona, Silvia Paola, D’Angelo, Alberto, Rosellini, Pietro, Nobili, Stefania, Mini, Enrico
Veröffentlicht in Int J Mol Sci (2020)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy

von Rodriquenz, Maria Grazia, Roviello, Giandomenico, D’Angelo, Alberto, Lavacchi, Daniele, Roviello, Franco, Polom, Karol
Veröffentlicht in J Clin Med (2020)

Mutant p53 as an Antigen in Cancer Immunotherapy

von Sobhani, Navid, D’Angelo, Alberto, Wang, Xu, Young, Ken H., Generali, Daniele, Li, Yong
Veröffentlicht in Int J Mol Sci (2020)

Advances in anti-BRAF therapies for lung cancer

von Roviello, Giandomenico, D’Angelo, Alberto, Sirico, Marianna, Pittacolo, Matteo, Conter, Felipe Umpierre, Sobhani, Navid
Veröffentlicht in Invest New Drugs (2021)

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

von Roviello, Giandomenico, D'Angelo, Alberto, Petrioli, Roberto, Roviello, Franco, Cianchi, Fabio, Nobili, Stefania, Mini, Enrico, Lavacchi, Daniele
Veröffentlicht in Transl Oncol (2020)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

von Sobhani, Navid, Ianza, Anna, D’Angelo, Alberto, Roviello, Giandomenico, Giudici, Fabiola, Bortul, Marina, Zanconati, Fabrizio, Bottin, Cristina, Generali, Daniele
Veröffentlicht in Cells (2018)

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

von Sobhani, Navid, Neeli, Praveen Kumar, D’Angelo, Alberto, Pittacolo, Matteo, Sirico, Marianna, Galli, Ilaria Camilla, Roviello, Giandomenico, Nesi, Gabriella
Veröffentlicht in Int J Mol Sci (2021)

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

von Sobhani, Navid, D’Angelo, Alberto, Pittacolo, Matteo, Roviello, Giandomenico, Miccoli, Anna, Corona, Silvia Paola, Bernocchi, Ottavia, Generali, Daniele, Otto, Tobias
Veröffentlicht in Cells (2019)

Methylene Blue—Current Knowledge, Fluorescent Properties, and Its Future Use

von Cwalinski, Tomasz, Polom, Wojciech, Marano, Luigi, Roviello, Giandomenico, D’Angelo, Alberto, Cwalina, Natalia, Matuszewski, Marcin, Roviello, Franco, Jaskiewicz, Janusz, Polom, Karol
Veröffentlicht in J Clin Med (2020)

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

von D’Angelo, Alberto, Sobhani, Navid, Chapman, Robert, Bagby, Stefan, Bortoletti, Carlotta, Traversini, Mirko, Ferrari, Katia, Voltolini, Luca, Darlow, Jacob, Roviello, Giandomenico
Veröffentlicht in Cancers (Basel) (2020)

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma

von D’Angelo, Alberto, Sobhani, Navid, Roviello, Giandomenico, Bagby, Stefan, Bonazza, Deborah, Bottin, Cristina, Giudici, Fabiola, Zanconati, Fabrizio, De Manzini, Nicolo, Guglielmi, Alessandra, Generali, Daniele
Veröffentlicht in PLoS One (2019)

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

von Roviello, Giandomenico, Ramello, Monica, Catalano, Martina, D’Angelo, Alberto, Conca, Raffaele, Gasperoni, Silvia, Dreoni, Lorenzo, Petrioli, Roberto, Ianza, Anna, Nobili, Stefania, Aieta, Michele, Mini, Enrico
Veröffentlicht in Sci Rep (2020)